Key Dates

Related Announcements

PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

The National Institute of General Medical Sciences (NIGMS) announces the availability of funds for an Administrative Supplement to an NIGMS-funded STTR Regional Technology Transfer Accelerator Hub (UT2) to provide business training for directors and staff of biomedical research core facilities funded by the Institutional Development Award (IDeA) Program . This award supports the development and delivery of a curriculum that introduces business fundamentals and best operational practices that will help improve the effectiveness and sustainability of the large number of IDeA-supported core facilities.

The curriculum should address (but not be limited to) the following concepts:

• Fundamental concepts in business operations such as value propositions, value creation, pricing standards, and marketing
• Best practices for business support
• Strategies and models that foster sustainability of research cores
• Risk assessment in the context of establishing, maintaining, managing, and growing core facilities
• Skills to address challenges such as hiring, budgeting, and staying up to date with evolving research technologies

The application also must describe plans for delivering the curriculum and evaluation. The target audience for the curriculum will primarily be core facility directors and will be open to principal investigators, core facility staff, post-doctoral fellows, and students. A strategy to reach out to potential curriculum participants must be included in the application. The curriculum can be developed into a product by the small business concern after piloting with the IDeA state core facility staff.

Applications from the STTR Regional Technology Transfer Hubs in response to this Notice of Special Interest (NOSI) must be electronically submitted to PA-20-272"Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)".

All instructions in the SF424 (R&R) Application Guide and in the target funding opportunity announcement (PA-20-272) must be followed with the following additions:

• The application due date is April 30, 2021 by 5:00 PM local time of the applicant organization.
• Applicants must include “NOT-GM-21-017” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
• Only electronic submissions will be accepted for this funding opportunity. Use one of the methods described in PA-20-272. Paper submissions and applications submitted as email attachments will be rejected without review.
• Only one supplement request per Hub will be accepted.
• Requests can be for no more than $50,000 in direct costs exclusive of Facilities and Administrative costs on sub-contracts. As part of the budget justification, a statement regarding the expenditure of currently available unobligated grant funds should be included to demonstrate the need for additional funds. Supplements may provide support above the established dollar limit for the parent grant award.
• Requests may be for one year of support only.
• The parent award must be active when the application is submitted (i.e., within the originally reviewed and approved project period), regardless of the time remaining on the current project.
• The Research Strategy section of the application is limited to 6 pages.
  • The Research Strategy should delineate the individual components and presentations to be included in the curriculum.
  • The Approach section must include the method of delivery of the curriculum.
• The application should include letters of support from individuals leading the development and delivery of key components of the curriculum.

Applicants are encouraged to contact the NIGMS Program Officer listed below to discuss potential plans and the proposed approach.

Inquiries

Please direct all inquiries to:

Federico Bernal, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: federico.bernal@nih.gov